SCHEMBL18318933

SCHEMBL18318933

CCC(=O)N1CCC(Oc2ccc(-c3ccc4c(Cl)ccnc4c3)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.48
PIK3CA P42336 9/20 0.48
PIK3CG P48736 6/20 0.48
PIK3CB P42338 6/20 0.48
SMYD3 Q9H7B4 1/20 0.44
NAMPT P43490 1/20 0.40
CCR5 P51681 1/20 0.40
EPHX2 P34913 2/20 0.40
IDE P14735 1/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2J2 P51589 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 2/20 0.39
FDPS P14324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18318543 0.88 ALDH1A1 (0.50) PIK3CDPIK3CAPIK3CGPIK3CBNAMPT
SCHEMBL18318074 0.84 PIK3CD (0.44) PIK3CDPIK3CAPIK3CGPIK3CBNAMPT
SCHEMBL18318671 0.83 PIK3CD (0.43) PIK3CDPIK3CAPIK3CGPIK3CBNAMPT
Hydrochloric Acid SCHEMBL18319302 0.83 PIK3CD (0.43) PIK3CDPIK3CAPIK3CGPIK3CBNAMPT
SCHEMBL18318970 0.82 EPHX2 (0.50) EPHX2KMT2A
SCHEMBL18319381 0.82 GSK3B (0.49) PIK3CDPIK3CAPIK3CGPIK3CBEPHX2
SCHEMBL18318344 0.81 PIK3CD (0.45) PIK3CDPIK3CAPIK3CGPIK3CBNAMPT
SCHEMBL18318477 0.81 PIK3CD (0.50) PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL18319861 0.81 PIK3CD (0.45) PIK3CDPIK3CAPIK3CGPIK3CBKMT2A
SCHEMBL18319017 0.81 NAMPT (0.49) NAMPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US claimed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US claimed
CN-107847765-B 1, 4-substituted piperidine derivatives 89生物有限公司 2021-05-04 CN claimed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP claimed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US claimed
US-20250257035-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2025-08-14 US disclosed
US-12098130-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2024-09-24 US disclosed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US disclosed
EP-3310441-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES Cephalon, Inc. (US) 2018-04-25 EP disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed
WO-2016205633-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 WO disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed
WO-2016205633-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257035-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885
US-12098130-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A PIK3CD 990/4885PIK3CA 752/4885PIK3CG 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.